Ardelyx (ARDX) News Today $4.00 +0.09 (+2.17%) As of 02:52 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ARDX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Two Sigma Advisers LP Increases Position in Ardelyx, Inc. (NASDAQ:ARDX)Two Sigma Advisers LP grew its stake in Ardelyx, Inc. (NASDAQ:ARDX - Free Report) by 206.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 593,700 shares of the biopharmaceutical company's stock after acquiring an additMay 29 at 3:58 AM | marketbeat.comVoloridge Investment Management LLC Has $4.54 Million Stock Holdings in Ardelyx, Inc. (NASDAQ:ARDX)Voloridge Investment Management LLC raised its position in Ardelyx, Inc. (NASDAQ:ARDX - Free Report) by 24.6% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 895,748 shares of the biopharmaceutical company's stock after acquiring an additiMay 28 at 4:47 AM | marketbeat.comArdelyx, Inc. (NASDAQ:ARDX) Shares Purchased by Two Sigma Investments LPTwo Sigma Investments LP boosted its position in shares of Ardelyx, Inc. (NASDAQ:ARDX - Free Report) by 16.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 1,141,777 shares of the biopharmaceutical company's stMay 28 at 4:09 AM | marketbeat.com2 ‘Strong Buy’ Small-Cap Stocks With Blockbuster PotentialMay 26 at 3:02 PM | msn.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardelyx, Inc. ...May 26 at 11:45 AM | gurufocus.comDeutsche Bank AG Boosts Position in Ardelyx, Inc. (NASDAQ:ARDX)Deutsche Bank AG increased its position in shares of Ardelyx, Inc. (NASDAQ:ARDX - Free Report) by 25.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 327,900 shares of the biopharmaceutical company's stockMay 26 at 3:30 AM | marketbeat.comArdelyx, Inc. (NASDAQ:ARDX) Insider Sells $26,197.68 in StockArdelyx, Inc. (NASDAQ:ARDX - Get Free Report) insider Laura A. Williams sold 6,421 shares of the company's stock in a transaction that occurred on Tuesday, May 20th. The stock was sold at an average price of $4.08, for a total value of $26,197.68. Following the transaction, the insider now directly owns 402,583 shares in the company, valued at approximately $1,642,538.64. This trade represents a 1.57% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.May 25, 2025 | marketbeat.comMillennium Management LLC Trims Stock Holdings in Ardelyx, Inc. (NASDAQ:ARDX)Millennium Management LLC lowered its holdings in Ardelyx, Inc. (NASDAQ:ARDX - Free Report) by 26.1% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 2,963,480 shares of the biopharmaceutical company's stock after selling 1,048,400 shares during the pMay 25, 2025 | marketbeat.comLaura A. Williams Sells 6,421 Shares of Ardelyx, Inc. (NASDAQ:ARDX) StockMay 24, 2025 | insidertrades.comInsider Selling: Ardelyx, Inc. (NASDAQ:ARDX) Insider Sells 2,507 Shares of StockMay 23, 2025 | insidertrades.comTwo Seas Capital LP Makes New Investment in Ardelyx, Inc. (NASDAQ:ARDX)Two Seas Capital LP purchased a new position in shares of Ardelyx, Inc. (NASDAQ:ARDX - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 1,855,337 shares of the biopharmaceutical compMay 23, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardelyx, Inc. - ARDXMay 22, 2025 | globenewswire.comPoint72 Asset Management L.P. Purchases New Position in Ardelyx, Inc. (NASDAQ:ARDX)Point72 Asset Management L.P. purchased a new stake in Ardelyx, Inc. (NASDAQ:ARDX - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 1,333,810 shares of the biopharmaceuticalMay 22, 2025 | marketbeat.comArdelyx to Participate at the Jefferies Global Healthcare Conference 2025May 21, 2025 | globenewswire.comSherbrooke Park Advisers LLC Acquires Shares of 66,623 Ardelyx, Inc. (NASDAQ:ARDX)Sherbrooke Park Advisers LLC acquired a new stake in Ardelyx, Inc. (NASDAQ:ARDX - Free Report) during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 66,623 shares of the biopharmaceutical company's stock, valued at approximatelyMay 21, 2025 | marketbeat.comBNP Paribas Financial Markets Boosts Holdings in Ardelyx, Inc. (NASDAQ:ARDX)BNP Paribas Financial Markets boosted its position in shares of Ardelyx, Inc. (NASDAQ:ARDX - Free Report) by 54.5% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 280,269 shares of the biopharmaceutical company's stock afterMay 21, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardelyx, Inc. - ARDXMay 20, 2025 | prnewswire.comInsider Buying: Ardelyx, Inc. (NASDAQ:ARDX) Director Purchases 100,000 Shares of StockMay 20, 2025 | insidertrades.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardelyx, Inc. ...May 18, 2025 | gurufocus.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardelyx, Inc. - ARDXMay 18, 2025 | globenewswire.comD. E. Shaw & Co. Inc. Buys 1,453,369 Shares of Ardelyx, Inc. (NASDAQ:ARDX)D. E. Shaw & Co. Inc. increased its holdings in shares of Ardelyx, Inc. (NASDAQ:ARDX - Free Report) by 9,499.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,468,668 shares ofMay 18, 2025 | marketbeat.comThe Manufacturers Life Insurance Company Sells 130,801 Shares of Ardelyx, Inc. (NASDAQ:ARDX)The Manufacturers Life Insurance Company lessened its holdings in shares of Ardelyx, Inc. (NASDAQ:ARDX - Free Report) by 52.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 117,123 shares of the biopharmaceutical cMay 18, 2025 | marketbeat.comArdelyx (NASDAQ:ARDX) Reaches New 1-Year Low - Here's WhyArdelyx (NASDAQ:ARDX) Sets New 1-Year Low - Should You Sell?May 16, 2025 | marketbeat.comJanus Henderson Group PLC Buys 2,858,061 Shares of Ardelyx, Inc. (NASDAQ:ARDX)Janus Henderson Group PLC raised its stake in shares of Ardelyx, Inc. (NASDAQ:ARDX - Free Report) by 13.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 24,387,941 shares of thMay 15, 2025 | marketbeat.comCubist Systematic Strategies LLC Takes $1.90 Million Position in Ardelyx, Inc. (NASDAQ:ARDX)Cubist Systematic Strategies LLC acquired a new stake in Ardelyx, Inc. (NASDAQ:ARDX - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 375,467 shares of the biopharmaceutical company's stock, valued at aMay 14, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardelyx, Inc. - ARDXMay 13, 2025 | globenewswire.comPrice T Rowe Associates Inc. MD Has $826,000 Stock Position in Ardelyx, Inc. (NASDAQ:ARDX)Price T Rowe Associates Inc. MD lowered its stake in Ardelyx, Inc. (NASDAQ:ARDX - Free Report) by 84.8% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 162,824 shares of the biopharmaceutical company's stock after selling 911,664 shares during thMay 13, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardelyx, Inc. ...May 12, 2025 | gurufocus.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardelyx, Inc. - ARDXMay 12, 2025 | prnewswire.comSchonfeld Strategic Advisors LLC Cuts Stake in Ardelyx, Inc. (NASDAQ:ARDX)Schonfeld Strategic Advisors LLC cut its position in Ardelyx, Inc. (NASDAQ:ARDX - Free Report) by 56.4% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 131,200 shares of the biopharmaceutical company's stock after selling 169,684 shares during the period. ScMay 12, 2025 | marketbeat.comArdelyx, Inc. (NASDAQ:ARDX) Receives Average Recommendation of "Moderate Buy" from BrokeragesShares of Ardelyx, Inc. (NASDAQ:ARDX - Get Free Report) have earned a consensus rating of "Moderate Buy" from the ten research firms that are currently covering the stock, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold recommendation, seven have assigned aMay 12, 2025 | marketbeat.com126,530 Shares in Ardelyx, Inc. (NASDAQ:ARDX) Acquired by Tudor Investment Corp ET ALTudor Investment Corp ET AL purchased a new stake in shares of Ardelyx, Inc. (NASDAQ:ARDX - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 126,530 shares of the biopharmaceutical company's stock, valued at approximately $642,May 10, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Ardelyx, Inc. - ARDXMay 9, 2025 | globenewswire.comFirst Trust Advisors LP Has $1.36 Million Stock Position in Ardelyx, Inc. (NASDAQ:ARDX)First Trust Advisors LP lessened its holdings in Ardelyx, Inc. (NASDAQ:ARDX - Free Report) by 53.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 268,924 shares of the biopharmaceutical company's stock after seMay 9, 2025 | marketbeat.comArdelyx (NASDAQ:ARDX) Shares Gap Up After Insider Buying ActivityArdelyx (NASDAQ:ARDX) Shares Gap Up Following Insider Buying ActivityMay 8, 2025 | marketbeat.comAlgert Global LLC Invests $4.98 Million in Ardelyx, Inc. (NASDAQ:ARDX)Algert Global LLC purchased a new stake in shares of Ardelyx, Inc. (NASDAQ:ARDX - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 983,084 shares of the biopharmaceutical company's stock, valued at approxiMay 8, 2025 | marketbeat.comRaymond James Financial Inc. Makes New $930,000 Investment in Ardelyx, Inc. (NASDAQ:ARDX)Raymond James Financial Inc. bought a new stake in Ardelyx, Inc. (NASDAQ:ARDX - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm bought 183,490 shares of the biopharmaceutical company's stock, valued at approximately $930,000. Raymond James FiMay 8, 2025 | marketbeat.comArdelyx showcases IBSRELA data at Digestive Disease WeekMay 7, 2025 | investing.comArdelyx (NASDAQ:ARDX) Trading Down 8.4% on Analyst DowngradeArdelyx (NASDAQ:ARDX) Trading Down 8.4% on Analyst DowngradeMay 7, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardelyx, Inc. - ARDXMay 6, 2025 | prnewswire.comArdelyx Presents Data Supporting IBSRELA® (tenapanor) at Digestive Disease Week 2025 ConferenceMay 6, 2025 | globenewswire.comInsider Selling: Ardelyx, Inc. (NASDAQ:ARDX) CEO Sells 41,666 Shares of StockMay 6, 2025 | insidertrades.comWedbush Weighs in on Ardelyx's Q4 Earnings (NASDAQ:ARDX)Ardelyx, Inc. (NASDAQ:ARDX - Free Report) - Equities research analysts at Wedbush boosted their Q4 2025 EPS estimates for Ardelyx in a report issued on Friday, May 2nd. Wedbush analyst L. Chico now forecasts that the biopharmaceutical company will post earnings of $0.01 per share for the quarter,May 6, 2025 | marketbeat.comScotiabank Remains a Buy on Ardelyx (ARDX)May 5, 2025 | theglobeandmail.comArdelyx (NASDAQ:ARDX) Announces Earnings ResultsArdelyx (NASDAQ:ARDX - Get Free Report) issued its quarterly earnings results on Thursday. The biopharmaceutical company reported ($0.17) EPS for the quarter, missing analysts' consensus estimates of ($0.10) by ($0.07). Ardelyx had a negative return on equity of 24.87% and a negative net margin of 11.73%. The business had revenue of $74.11 million for the quarter, compared to analyst estimates of $79.40 million. During the same quarter last year, the firm earned ($0.11) earnings per share. The firm's quarterly revenue was up 61.1% compared to the same quarter last year.May 5, 2025 | marketbeat.comHsbc Holdings PLC Acquires New Position in Ardelyx, Inc. (NASDAQ:ARDX)Hsbc Holdings PLC acquired a new stake in Ardelyx, Inc. (NASDAQ:ARDX - Free Report) during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor acquired 281,764 shares of the biopharmaceutical company's stock, valued at approximately $1,423,0May 5, 2025 | marketbeat.comMarshall Wace LLP Takes Position in Ardelyx, Inc. (NASDAQ:ARDX)Marshall Wace LLP bought a new position in shares of Ardelyx, Inc. (NASDAQ:ARDX - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 114,819 shares of the biopharmaceutical compMay 5, 2025 | marketbeat.comArdelyx (NASDAQ:ARDX) Hits New 1-Year Low Following Weak EarningsArdelyx (NASDAQ:ARDX) Reaches New 52-Week Low Following Weak EarningsMay 4, 2025 | marketbeat.comArdelyx (NASDAQ:ARDX) Cut to Outperform at Raymond JamesRaymond James lowered Ardelyx from a "strong-buy" rating to an "outperform" rating and set a $11.00 price objective on the stock. in a research note on Friday.May 4, 2025 | marketbeat.comEarnings call transcript: Ardelyx Inc Q1 2025 sees stock drop after earnings missMay 4, 2025 | uk.investing.com Get Ardelyx News Delivered to You Automatically Sign up to receive the latest news and ratings for ARDX and its competitors with MarketBeat's FREE daily newsletter. Email Address ARDX Media Mentions By Week ARDX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ARDX News Sentiment▼0.630.87▲Average Medical News Sentiment ARDX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ARDX Articles This Week▼189▲ARDX Articles Average Week Get Ardelyx News Delivered to You Automatically Sign up to receive the latest news and ratings for ARDX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SRPT News Today AKRO News Today RNA News Today ACAD News Today CYTK News Today PTCT News Today KRYS News Today ACLX News Today SWTX News Today ZLAB News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ARDX) was last updated on 5/29/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ardelyx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ardelyx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ARDX Stock Free ARDX Stock Alerts